AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $32,000 | +23.1% | 472 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $26,000 | 0.0% | 472 | 0.0% | 0.01% | -86.8% |
| Q4 2017 | $26,000 | +18.2% | 472 | 0.0% | 0.07% | +655.6% |
| Q3 2017 | $22,000 | -8.3% | 472 | 0.0% | 0.01% | -10.0% |
| Q2 2017 | $24,000 | -80.3% | 472 | -82.3% | 0.01% | -80.0% |
| Q1 2017 | $122,000 | -43.0% | 2,672 | -52.7% | 0.05% | -13.8% |
| Q4 2016 | $214,000 | -30.3% | 5,644 | -30.7% | 0.06% | -52.1% |
| Q3 2016 | $307,000 | +114.7% | 8,144 | 0.0% | 0.12% | +108.6% |
| Q2 2016 | $143,000 | +44.4% | 8,144 | 0.0% | 0.06% | +23.4% |
| Q1 2016 | $99,000 | -50.0% | 8,144 | 0.0% | 0.05% | -51.5% |
| Q4 2015 | $198,000 | – | 8,144 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |